Hyperbaric Oxygen Therapy Market Report 2026

Hyperbaric Oxygen Therapy Market Overview

• Hyperbaric Oxygen Therapy market size has reached to $4.9 billion in 2025 • Expected to grow to $7.89 billion in 2030 at a compound annual growth rate (CAGR) of 9.7% • Growth Driver: The Increasing Prevalence Of Diabetes Drives Growth In The Hyperbaric Oxygen Therapy Market • Market Trend: Innovative Hyperbaric Oxygen Therapy Products Revolutionize Patient Care • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Hyperbaric Oxygen Therapy Market?

Hyperbaric oxygen therapy (HBOT) is a medical treatment that involves breathing pure oxygen in a pressurized chamber or room. It is used to treat a variety of medical conditions, including decompression sickness (the bends), carbon monoxide poisoning, non-healing wounds, radiation injuries, and certain infections. The main product types of the hyperbaric oxygen therapy market are monoplace hyperbaric oxygen therapy, multiplace hyperbaric oxygen therapy, and topical hyperbaric oxygen therapy devices. Monoplace hyperbaric oxygen therapy chambers are designed to accommodate a single patient at a time, typically in a reclining position. The various applications include wound healing, decompression sickness, infection treatment, gas embolism, and other applications used by various end-users such as hospitals and clinics ambulatory surgery centers, and other end-users.

What Is The Hyperbaric Oxygen Therapy Market Growth Forecast?

The hyperbaric oxygen therapy market size is expected to see strong growth in the next few years. It will grow to $7.89 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to growing diabetic population with wound complications, technological advancements in chamber design, expanding outpatient and ambulatory use, rising awareness among healthcare providers, increasing reimbursement support in select regions. Major trends in the forecast period include expanding use of hbot in chronic wound management, growing adoption of portable and monoplace hbot systems, increasing clinical acceptance of hbot for radiation injuries, rising integration of hbot in multidisciplinary treatment protocols, expansion of hbot applications beyond traditional indications.

What Is The Driver Of The Hyperbaric Oxygen Therapy Market?

The rise in diabetes prevalence is expected to propel the growth of the hyperbaric oxygen therapy market going forward. Diabetes refers to a group of chronic metabolic disorders characterized by high blood sugar levels over a prolonged period of time. Diabetes is increasing due to sedentary lifestyles, poor diets, obesity, and genealogy. Hyperbaric oxygen therapy (HBOT) is used in the treatment of diabetes-related complications, particularly diabetic foot ulcers and other non-healing wounds. For instance, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people globally were living with diabetes. This number is expected to more than double, reaching 1.3 billion people by 2050. Therefore, a rise in diabetes prevalence is driving the hyperbaric oxygen therapy industry.

Key Players In The Global Hyperbaric Oxygen Therapy Market

Major companies operating in the hyperbaric oxygen therapy market are Healogics LLC, SOS Medical Group Ltd., Environmental Tectonics Corporation, Sechrist Industries Inc., BioBarica Profesionales, Perry Baromedical Corporation, Shanghai Baobang Medical Equipment Co. Ltd., Hyperbaric Modular Systems Inc., Baroks Hyperbaric, Haux-Life-Support GmbH, Haux-Technik GmbH, Hyperbaric SAC, Pan America Hyperbarics Inc., OxyHeal Health Group, Fink Engineering Pty Ltd, AHA Hyperbarics, The Oxybarica Group, NHC Medical And Beauty, Hyperbaric Medical Solutions, Gulf Coast Hyperbarics, Hearmec Co. Ltd., Hpotech Hyperbaric Solutions

Global Hyperbaric Oxygen Therapy Market Trends and Insights

Major companies operating in the hyperbaric oxygen therapy market are developing innovative products, such as hyperbaric chambers, to better serve customers with advanced features. Hyperbaric chambers are specialized medical devices that create a pressurized environment to administer hyperbaric oxygen therapy (HBOT), allowing patients to breathe pure oxygen and enhance oxygen delivery to body tissues. For instance, in January 2024, Sechrist Industries Inc., a US-based hyperbaric technology and medical equipment manufacturer, launched the 3300 HM Hyperbaric Chamber. The 3300 HM Hyperbaric Chamber offers an expansive interior designed for enhanced patient comfort and accessibility, accommodating a wide range of patient sizes and mobility needs. Equipped with advanced monitoring systems, it ensures real-time tracking of vital signs and chamber conditions, enhancing patient safety. The chamber also includes state-of-the-art oxygen delivery systems that optimize the efficiency of oxygen intake, and its user-friendly interface allows for easy operation by healthcare professionals.

What Are Latest Mergers And Acquisitions In The Hyperbaric Oxygen Therapy Market?

In July 2023, O2 Worx Ltd, a UK-based manufacturing company that specializes in manufacturing of pressurized chambers for hyperbaric oxygen therapy (HBOT), partnered with SMP - Submarine Manufacturing & Products Ltd. The partnership aims to expand the reach of hyperbaric oxygen chambers by leveraging O2 Worx’s health and wellness expertise alongside SMP’s established medical and diving industry presence. Together, they will enable wider deployment, enhanced training, and superior service for hyperbaric therapy in new markets. SMP - Submarine Manufacturing & Products Ltd is a Uk-based manufacturing company that specializes in manufacturers and suppliers of commercial diving equipment.

What Defines the Hyperbaric Oxygen Therapy Market?

The hyperbaric oxygen therapy market consists of sales of hyperbaric oxygen chambers, monitoring and cardiac support devices, oxygen delivery systems, medical gowns, and clear plastic tubes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Hyperbaric Oxygen Therapy Market Report 2026?

The hyperbaric oxygen therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hyperbaric oxygen therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.